2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
5
Unknown
2
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6384
Neoplasms
5356
Prostatic Neoplasms
2964
Carcinoma, Non-Small-Cell Lung
2704
Colorectal Neoplasms
2674
Lung Neoplasms
2262
Multiple Myeloma
1656
Lymphoma
1598
Neoplasm Metastasis
1550
Leukemia, Myeloid, Acute
1537
Melanoma
1484
Pancreatic Neoplasms
1470
Ovarian Neoplasms
1420
Leukemia
1387
Head and Neck Neoplasms
1283
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1279
Lymphoma, Non-Hodgkin
1226
Colonic Neoplasms
1157
Carcinoma, Hepatocellular
1141
Stomach Neoplasms
1126
Leukemia, Lymphocytic, Chronic, B-Cell
1089
Brain Neoplasms
1048
Rectal Neoplasms
979
Lymphoma, Follicular
978
Recurrence
971
Uterine Cervical Neoplasms
923
Glioblastoma
916
Carcinoma, Renal Cell
881
Lymphoma, Large B-Cell, Diffuse
851
Hodgkin Disease
775
Interventions
Stents
1
Ethiodized Oil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
HCC
×
Clear all
NCT04123340
2023-01-06
IAMCOMPLETE
Leiden University Medical Center
Phase 2
Completed
20 enrolled
NCT03108248
2017-04-11
ISP-TACE Versus TACE for HCC With PVTT
Zhongda Hospital
Completed
126 enrolled